Details for 2019759294

Up to date per 26.05.2026

Actions

Title / Product Name

VERFAHREN ZUR BEHANDLUNG VON HFPEF MIT DAPAGLIFLOZIN UND ZUSAMMENSETZUNGEN DAMIT

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019759294

EP Publication Number

3823631

E-Number

1923317

Language

PCT Number

EP19069323

Publication Date

26.05.2021 A

20.05.2026 B1

Registration Date

20.05.2026

AT Publication Date

15.06.2026

Application Date

18.07.2019

Registration Number

Priorities

19.07.2018

201862700463 P

IPC

A61K 31/70 20060101AFI20200124BHEP

Maximum Duration of Protection

18.07.2039

Owner

Astrazeneca AB 151 85 SödertäljeSE

Representative

No representatives present

Inventor

LANGKILDE, Anna, MariaAstraZeneca 151 85 SödertäljeSE

Information about Fees